A new study reports how well people with depression respond to placebos may determine how well they will respond to antidepressant medications.
Researchers shed light on how the mammalian brain processes critical social information.
Computational simulations reveal the integration of both neuronal and neurotransmitter systems at a whole-brain level is vital to fully understand the effects of psilocybin on brain activity.
Researchers report on finding symptoms of Alzheimer's disease in an HIV positive patient.
Smokers may have reduced neuroimmune function compared to their non-smoking peers. Researchers report restoring the immune system may benefit smokers. Immune dysfunction is linked to cognitive dysfunction.
According to a new study in eLife, adults who were born prematurely or who suffered small brain injuries around the time of birth have reduced dopamine levels.
According to researchers, people who consider themselves to be recreational cocaine users may be closer to addiction than they think.
A link between liver dysfunction and Alzheimer's disease has been discovered. The findings add to the understanding of the role metabolic dysfunction plays in the neurodegenerative disease.
A new convolutional neural network uses PET brain scans to detect biological signs of Alzheimer's disease years before the symptoms appear, researchers report.
People with higher levels of dopamine in the striatum perform worse after being promised a bonus, a new study reports.
Parkinson's disease can be divided into two variants that start in different places in the body. For some, the neurodegenerative disease starts in the intestines and spreads to the brain. In others, the disease begins in the brain and spreads to the intestines and other organs.
A new study reveals people with schizophrenia have a disrupted stress response. Researchers report those with schizophrenia have an increase in dopamine release in the striatum, but not in the prefrontal cortex, in response to stress.
